This research was to study the treatment and therapeutic drug monitoring of vancomycin,
one of the most prescribed antibiotics in pediatric intensive care units in US hospitals, from a …

Background: Vancomycin treatment failures in adults with methicillin-resistant
Staphylococcus aureus bacteremia are well documented despite established therapeutic …

Aims This study aims to investigate prescribing and therapeutic drug monitoring (TDM)
practices for vancomycin in paediatrics at the Jordan University Hospital and to determine …

Background: Deviations from the optimal vancomycin dosing may occur in the neonatal and
pediatric population due to inconsistencies in the recommended dosing algorithms. This …

Background: Therapeutic drug monitoring (TDM) is routinely used for optimization of
vancomycin therapy, because of exposure-related efficacy and toxicity, in addition to …

OBJECTIVES The primary objective of this retrospective study was to determine if
implementation of vancomycin monitoring criteria could reduce the number of serum …

Introduction: The use of vancomycin is common among hospitalized children. We sought to
evaluate the impact of prospective audit with real-time feedback on vancomycin use and …

Background Vancomycin optimization is challenging, requiring careful therapeutic drug
monitoring (TDM) to avoid toxicity and ensure an efficacious concentration. Most …

Monitoring of vancomycin trough concentrations is recommended for pediatric patients in the
product label and by several professional societies. However, among a network of …

Objectives: To characterize vancomycin use at a pediatric tertiary-care hospital, to
discriminate between initial (≤ 72 hours) and prolonged (> 72 hours) inappropriate use, and …